✦ LIBER ✦

GM-CSF as an adjunct to autologous bone marrow transplantation

✍ Scribed by S. Gulati; C. Bennett; J. Phillips; C. Van-Poznak

Book ID: 112212442
Publisher: AlphaMed Press
Year: 1993
Tongue: English
Weight: 433 KB
Volume: 11
Category: Article
ISSN: 1066-5099
DOI: 10.1002/stem.5530110105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical use of GM-CSF in autologous bon

Clinical use of GM-CSF in autologous bone marrow transplantation

✍ A. M. Carella; E. Gaozza; G. Piatti; P. Carlier; M. R. Raffo; A. S. Nati; A. Con 📂 Article 📅 1990 🏛 AlphaMed Press 🌐 English ⚖ 249 KB

Vascularized Bone Marrow Transplantation

Vascularized Bone Marrow Transplantation Model in Rats as an Alternative to Conventional Cellular Bone Marrow Transplantation: Preliminary Results

✍ D. Zamfirescu; C. Popovicu; A. Stefanescu; A. Bularda; M. Popescu; I. Zegrea; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Prospective economic evaluation accompan

Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin’s and non-Hodgkin’s lymphoma

✍ Schulman, K A; Dorsainvil, D; Yabroff, K R; DiCesare, J; Felser, J; Eisenberg, J 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

PEG-ADA: An alternative to haploidentica

PEG-ADA: An alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency

✍ Michael S. Hershfield 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency. Treatment with PEG-ADA almost completely corrects metabolic abnormalities, allowing the recovery of a variable

Psychological support to an autologous b

Psychological support to an autologous bone marrow transplant unit in a community hospital: a pilot experience

✍ Joseph J. Amato; Martha Williams; Carol Greenberg; Michael Bar; Steve Lo; Isidor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Autologous Bone Marrow Transplantation (AuBMT) has emerged as an efficacious treatment for certain hematological and solid tumors. Some of the complications of allogeneic transplants are avoided with an autologous transplant. Due to the decreased toxicity of this procedure, AuBMT can be administered

Peripheral blood stem cell transplantati

Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?

✍ Vellenga, E; van Putten, W L J; Boogaerts, M A; Daenen, S M G J; Verhoef, G E G; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB